News and activities

The International Society of Cell & Gene Therapy (ISCT) will provide 2 EV sessions on their regional meeting in Florence (September 12-14, 2018). The meeting covers some interesting translational aspects.

1st Mini-Symposium “Extracellular Vesicles in Trans-Kingdom Communication in München (LMU)

More information below.

1st Mini-Symposium “Extracellular Vesicles in Trans-Kingdom Communication"
1st Mini-Symposium Extracellular Vesicle[...]
PDF-Dokument [1.6 MB]

GSEV was present at the Annual Meeting of the International Society for Extracellular Vesicles in Barcelona in May 2018 - see an update and a few impressions below!

A few weeks have come and gone, and after gathering our thoughts and sifting through our notes, we’d like to provide the community with a quick summary report on ISEV2018.

 

To begin with: Even though everybody was happy that, out of all places, sunny Barcelona was selected for ISEV’s 7th annual meeting, the weather was a huge surprising factor. It was usually rather cold, rainy and windy around the conference center. Seeing it from a positive perspective, it was very easy to stay inside all day and listen to talks – no distractions by means of sunny walks at Park Güell, sangria after visiting la Sagrada Familia or café con leche.

 

GSEV had a strong presence at the meeting, bringing members from Essen, Marburg, Mainz, Munich, Heidelberg, Freiburg and elsewhere. As usual, participants of the German delegation joined forces quickly and set out to explore Barcelona (after enjoying packed 12-hour days of EV science, of course!). Scientists from all branches of the field gathered in the city’s restaurants and pubs, reconnected with colleagues and got to know each other better. Over tapas and beer, it was instantly clear: these people are great – it’s good to be here!

 

Similarly, more and more national EV societies start sprouting worldwide, many of which presented themselves at ISEV’s evening events. As these societies are often founded by members of the former COST initiative for a European Network on Microvesicles and Exosomes in Health and Disease (ME-HAD), many local organizers know each other very well, paving the way for active collaborations among the different national societies, e.g. in transnational collaboration projects. While the field is growing rapidly (it was the first annual meeting with more than 1000 participants), the community is still close-knit and familial, both on the international and German level.

Boosted by the ever growing interested in EVs, more and more biotech, diagnostic and equipment companies team up with researchers and societies. As evidenced in the industrial exhibition and sponsor talks, these alliances, and the bottom-up feedback from researchers in the field, lead to the development of extremely useful tools, which will ultimately propel EV science forward. While previous meetings were heavily focused on advances in bulk EV characterization, the trend now seems to move towards sophisticated and ultra-pure methods for EV isolation as well as high-resolution phenotyping of individual vesicles.

 

Back to the meeting itself: Headed by Juan Falcón-Pérez, the Local Organizing Committee together with ISEV did a great job putting together an agenda that covered an immense breadth of vesicle research. Dozens of talks and hundreds of posters captured everything from A(rgonaute proteins – should they be present in EVs or do we regard them as contaminants?) to Z(etaView: now available as TwinNTA, providing two lasers in one device). After an opening ceremony with opera singers and a live piano (you don’t get that at most conferences!), ISEV2018 was on, featuring four days with more highlights than could be recounted here.

 

Three parallel tracks of symposium sessions were interspersed with plenary talks by scientific heavyweights such as Graça Raposo (reflecting on the cell biology of extracellular vesicles), Mina Bissell (urging researchers to refuse dogma and start thinking outside the box) and Nobel Laureate Randy Shekman, who brought up thought-provoking ideas about the mechanisms of RNA sorting into EVs. Additional highlights included the 3D virtual animation on extracellular vesicles presented by Dave Carter (now available on YouTube) and the MISEV II initiative that all ISEV members were encouraged to participate in. We are very excited about the upcoming results.

 

GSEV members were not only passive attendants at the meeting, but also contributed in various ways: our president Bernd Giebel summed up one at the educational sessions, chaired the symposium session on Tissue Injury and Repair and displayed his expertise on Leukemia EVs during Saturday’s Meet the Expert Session. Additionally, he introduced GSEV at the Meet the National Societies event. The vice president, Eva-Maria Krämer-Albers, chaired Mina Bissel’s keynote lecture and a poster session, and presented her work on using transgenic mouse models to elucidate the spatio-temporal intricacies of glia to neuron exosome transfer. GSEV’s executive director Irina Nazarenko also served as session chair and gave a talk about her work on the clinical relevance of mutated, oncogenic nucleic acids in various EV subtypes. Martin Auber, a graduate student in Krämer-Albers’ lab, received a well-deserved poster prize (cheers!) for his research on how miRNAs from serum-free media supplements co-purify with EVs, potentially skewing experiments on cell culture-derived vesicles. Last but not least, a couple of other GSEV members presented their work on posters and in selected abstract talks.

 

Preceded by the Education Day and rounded off with numerous additional events (Meet the Experts, Meet the Journal Editors, Satellite Events, a luncheon for young researchers’ career development and many more), ISEV2018 certainly raised the bar for next year’s meeting in Kyoto, Japan. Hasta entonces and すぐに会いましょ.

Biobarriers 2018

with EV session

 

The 12th International Conference and Workshop on Biological Barriers is an international scientific event, organized every two years and receiving constantly 200+ registered attendees from all over the world.

In the focus of BioBarriers 2018 are human cell and tissue models for facilitating clinical translation of new drugs and delivery systems, especially in the context of infectious diseases.

 

This year, Biobarriers will host a one-day session on EVs. Confirmed speakers for this session are Raymond Schiffelers (Utrecht), Dave Carter (Oxford Brooks) and David Whitworth (Aberysthwyth).

 

Registration can be done via the official Biobarriers webpage.

 

GSEV members will receive a discount for a one-day registration and will be preferred for the contributed talks

 

For further information see Biobarriers webpage or contact us at info@extracellular-vesicles.de

26. April 2018 - Treffen der EV-Wissenschaftler in der Region Rhein-Neckar

 

Am 26. April 2018 wird in Heidelberg der Austausch über Extrazelluäre Vesikel durch das Zusammentreffen von EV-interessierten Wissenschaftlerinnen und Wissenschaftlern aus verschiedenen Instituten erneut intensiviert.

Neben dem wissenschaftlichen Wissenstransfer über verschiedene EV-Themen und Forschungsprojekte, steht auch die Vernetzung der EV-Forscher/-innen im Fokus. Alle interessierten EV-Wissenschaftlerinnen und Wissenschaftler aus der Region sind herzlich zu diesem spannenden EV-Treffen eingeladen.

 

Bei Interesse und für weitere Informationen kontaktieren Sie bitte Fabia Fricke (f.fricke@dkfz-heidelberg.de).

Australasian Extracellular Vesicles Conference

November 14-16, 2018

Sydney, Australia

ISEV Position papers - GSEV reccomends reading these manuscripts published by the International Society for Extracellular Vesicles (full text access in the member area)

German Society for Extracellular Vesicles

March 2017

 

The kick-off meeting for the new German network on EVs was held on 2 March 2017 in a parallel session of the 2017 IGLD Meeting in Düsseldorf.

Press release GSEV
Pressemeldung_GSEV_final_korr.pdf
PDF-Dokument [159.0 KB]

Links to other EV networks

Druckversion Druckversion | Sitemap
© Gregor Fuhrmann Powered by 1&1